MedPath

CORIUM, INC.

CORIUM, INC. logo
🇺🇸United States
Ownership
Private
Established
1999-01-01
Employees
251
Market Cap
-
Website
https://corium.com

Clinical Trials

8

Active:1
Completed:7

Trial Phases

2 Phases

Phase 1:6
Phase 4:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 1
6 (75.0%)
Phase 4
2 (25.0%)

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

Phase 4
Active, not recruiting
Conditions
Attention Deficit/Hyperactivity Disorder
Interventions
First Posted Date
2023-02-09
Last Posted Date
2025-06-27
Lead Sponsor
Corium, Inc.
Target Recruit Count
123
Registration Number
NCT05721235
Locations
🇺🇸

Preferred Research Partners (PRP), Little Rock, Arkansas, United States

🇺🇸

Advanced Research Center (ARC), Anaheim, California, United States

🇺🇸

IMMUNOe International Research Center, Centennial, Colorado, United States

and more 17 locations

An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD

Phase 4
Completed
Conditions
Attention Deficit/Hyperactivity Disorder
Interventions
First Posted Date
2023-01-17
Last Posted Date
2025-05-13
Lead Sponsor
Corium, Inc.
Target Recruit Count
246
Registration Number
NCT05685732
Locations
🇺🇸

Preferred Research Partners (PRP), Little Rock, Arkansas, United States

🇺🇸

Advanced Research Center (ARC), Anaheim, California, United States

🇺🇸

IMMUNOe International Research Center, Centennial, Colorado, United States

and more 17 locations

Crossover Pharmacokinetic (PK) Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Subjects
Interventions
Combination Product: Donepezil TDS
First Posted Date
2020-11-05
Last Posted Date
2021-05-21
Lead Sponsor
Corium, Inc.
Target Recruit Count
60
Registration Number
NCT04617782
Locations
🇺🇸

Worldwide Clinical Trials, San Antonio, Texas, United States

A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)

Phase 1
Completed
Conditions
Alzheimer's Disease
Interventions
First Posted Date
2018-02-19
Last Posted Date
2018-09-14
Lead Sponsor
Corium, Inc.
Target Recruit Count
24
Registration Number
NCT03438604
Locations
🇺🇸

Celerion, Phoenix, Arizona, United States

A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations

Phase 1
Completed
Conditions
Alzheimer's Disease
Interventions
First Posted Date
2018-02-14
Last Posted Date
2018-08-07
Lead Sponsor
Corium, Inc.
Target Recruit Count
66
Registration Number
NCT03432195
Locations
🇺🇸

Celerion, Tempe, Arizona, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.